Time to revisit the use of G-CSF after allogeneic haematopoietic cell transplantation in COVID-19 era?
Br J Cancer
; 124(7): 1183, 2021 03.
Article
in English
| MEDLINE | ID: covidwho-1007651
ABSTRACT
The use of granulocyte colony-stimulating factor (G-CSF) in patients with haematological malignancies is associated with less febrile neutropenia episodes. But in the presence of COVID-19 infection, the administration of G-CSF is challenging as it may trigger a robust inflammatory reaction resulting in cytokine storm, respiratory failure and severe outcomes.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Granulocyte Colony-Stimulating Factor
/
Hematopoietic Stem Cell Transplantation
/
Hematologic Neoplasms
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Br J Cancer
Year:
2021
Document Type:
Article
Affiliation country:
S41416-020-01195-8
Similar
MEDLINE
...
LILACS
LIS